Fig. 3From: A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verificationSurvival analysis of 6 key genes (A) AURKA, (B) BIRC5, (C) CCNB1, (D) CDK1, (E) CDKN3 and (F) TYMSBack to article page